LOGO
LOGO

Will INFRONT-3 Data Bring Alector To The Forefront Of Frontotemporal Dementia Treatment?

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
frontotemporal 02102025 lt

There are said to be roughly 18,500 recognized diseases worldwide - yet only about 4,000 have FDA-approved treatments, according to Every Cure, an AI-powered nonprofit biotech organization. Frontotemporal dementia, a rapidly progressive form of dementia, is one such disease with no approved treatment.

It is estimated that about 50,000 to 60,000 people in the U.S. and approximately 110,000 people in the EU have Frontotemporal dementia (FTD). This rare neurodegenerative disease strikes people between the ages of 45 and 64 and is often characterized by behavioural changes, lapses in judgment, and diminished language skills.

Subscribe to continue reading the article.
This article is available exclusively to RTT Biotech Investor and Intelligent Investor subscribers. Subscribe with a RTTNews subscription.
Start Free Trial
FREE 7-Day Trial - No Payment Required
Already subscribed? Sign in

For comments and feedback contact: editorial@rttnews.com

Global Economics Weekly Update -June 15 - June 19, 2026

June 19, 2026 16:46 ET
Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.